Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-FLUOXETINE | 20MG | CAPSULE | Resolved | 2024-02-23 | 2024-03-01 | 220453 |
| APO-FLUOXETINE | 20MG | CAPSULE | Resolved | 2024-02-26 | 2024-03-01 | 220650 |
| APO-FLUOXETINE | 10MG | CAPSULE | Resolved | 2024-12-11 | 2025-03-14 | 245456 |
| APO-FLUOXETINE | 20MG | CAPSULE | Resolved | 2024-12-11 | 2025-03-14 | 245459 |
| APO-FLUOXETINE | 20MG | CAPSULE | Avoided shortage | 2024-12-11 | 2025-04-10 | 245462 |
| APO-FLUTICASONE HFA | 125MCG | METERED-DOSE AEROSOL | Resolved | 2023-02-23 | 2023-03-02 | 185486 |
| APO-FLUTICASONE HFA | 125MCG | METERED-DOSE AEROSOL | Resolved | 2023-10-27 | 2023-11-06 | 208406 |
| APO-FLUTICASONE HFA | 125MCG | METERED-DOSE AEROSOL | Resolved | 2024-07-12 | 2024-08-09 | 232835 |
| APO-FLUTICASONE HFA | 125MCG | METERED-DOSE AEROSOL | Resolved | 2024-11-14 | 2024-12-20 | 243089 |
| APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2022-09-01 | 2022-10-07 | 168367 |
| APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2022-12-23 | 2023-02-17 | 179453 |
| APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2023-04-06 | 2023-07-27 | 188940 |
| APO-FLUVOXAMINE | 100MG | TABLET | Resolved | 2023-10-20 | 2024-01-19 | 207710 |
| APO-FLUVOXAMINE | 100MG | TABLET | Resolved | 2024-04-05 | 2024-05-17 | 224592 |
| APO-FLUVOXAMINE | 100MG | TABLET | Resolved | 2017-06-28 | 2018-03-04 | 14171 |
| APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2017-06-28 | 2018-03-04 | 14174 |
| APO-FLUVOXAMINE | 100MG | TABLET | Resolved | 2020-09-22 | 2020-11-02 | 124786 |
| APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2020-10-14 | 2020-11-02 | 126280 |
| APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2021-03-05 | 2021-03-29 | 135162 |
| APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2021-10-15 | 2021-11-29 | 147292 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |